Forensic Genomics Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global Forensic Genomics Market Trends and Insights

Advancements in Next-Generation Sequencing (NGS) for Complex Forensic DNA Analysis

Next-generation sequencing moved into a lead position in 2025, with more than half of the forensic genomics market tied to this method by revenue. This marks a clear change from the older pattern where capillary electrophoresis defined most routine forensic DNA work. A 2025 peer-reviewed study showed that sequencing 26 autosomal STR loci reduced random match probability by more than 700 times compared with conventional CE-STR analysis, and flanking region variation improved discrimination further.^{[1]L. Devesse et al., “Implementation of NGS and SNP Microarrays in Routine Forensic Practice, Opportunities and Barriers,” BMC Genomics, springer.com}That performance matters in the forensic genomics market because mixed samples, low template samples, and degraded remains remain common in actual investigations and identification work. QIAGEN’s ForenSeq Kintelligence HT Kit reflects the same shift, because it is built around 10,230 SNP markers for kinship work and degraded skeletal remains, which shows that vendors are designing products for the hardest cases rather than only for routine workflows.^{[2]QIAGEN, “ForenSeq Kintelligence HT Kit,” QIAGEN, qiagen.com} The forensic genomics market is therefore moving toward platforms that combine stronger discrimination, broader sample compatibility, and richer evidentiary output, even though laboratories still need more dedicated bioinformatics support before this transition can scale fully.

Expansion of National DNA Databases and Kinship Matching Programs

The forensic genomics market is closely linked to the continuing expansion of national DNA databases, because each additional profile makes the value of database participation more visible to law enforcement agencies and public funders. FBI statistics for late 2025 showed that NDIS stored more than 24.8 million offender DNA profiles and had aided more than 758,449 investigations, which keeps the case for continued spending on kits, instruments, and lab processing capacity firmly in place.^{[3]Federal Bureau of Investigation, “CODIS-NDIS Statistics,” FBI Law Enforcement, fbi.gov} In the United States, the CODIS Access Modernization Act would allow eligible private forensic laboratories to upload qualifying DNA profiles directly to NDIS, which would broaden the commercial base beyond public sector labs if adopted. As more countries tighten operating rules around chain of custody, validation, and upload quality, the forensic genomics market gains volume, while established suppliers gain an advantage because their systems are better positioned to meet formal standards.

Growth in Rapid DNA and Portable Sequencing Adoption in Field Workflows

Rapid DNA is expanding the forensic genomics market by changing where analysis can happen, not only how quickly it can be completed. The Consortium of Forensic Science Organizations stated that a Rapid DNA instrument costs USD 250,000 per unit and cited a return of USD 1,070.62 for every USD 1.00 invested, which gives procurement teams a concrete operating case for use at booking stations and mass casualty sites. The forensic genomics market is therefore opening new demand pockets in remote law enforcement units, field response teams, and temporary processing sites that traditional bench-based workflows could not serve. China’s fully integrated forensic DNA detection system, recognized among the country’s Top 10 Biomedical Technology Advances for 2025, adds to that shift by showing that one-hour, lab free operation is now a realistic design target in the region.

Increasing Adoption of Forensic DNA Phenotyping and Investigative Genetic Genealogy

The forensic genomics market is also widening through applications that sit next to routine criminal casework, especially paternity, kinship, and investigative genealogy uses. Paternity and familial testing already represented the largest therapeutic area in 2025, which matters because this demand is tied not only to police budgets but also to courts, immigration cases, inheritance disputes, and direct relationship testing. The result is a broader and more stable addressable base for the forensic genomics market, even though adoption still depends on privacy rules, judicial oversight, and the availability of capable service providers.

High Capital and Validation Cost of Sequencers and Reference Workflows

The forensic genomics market still faces a meaningful access barrier because capital requirements remain high for both equipment and compliance. Rapid DNA systems alone carry an instrument price near USD 250,000, and laboratories that shift into next-generation sequencing must also fund supporting software, data storage, and validation work before they can use new workflows in casework. The cost burden therefore reaches beyond instrument purchase and extends into training, documentation, data handling, and the time laboratories lose while new workflows are being qualified. The forensic genomics market can continue to grow under those conditions, but adoption will remain uneven where laboratories have limited budgets or where new capacity is still being built from the ground up.

Cross-Border Data Governance and Privacy Constraints on DNA Data Sharing

The forensic genomics market also faces a structural limit in the way DNA data is governed across borders. Databases are typically built at the national level, while crime, migration, and identification needs often cross jurisdictions, which creates an operational gap between technical capability and legal permission. Even where automated comparison frameworks exist, vendors still face differences in STR loci panels, data formats, and privacy rules that complicate standardization and raise localization costs. In the forensic genomics market, that fragmentation means products often need country specific validation and workflow adaptation before they can be deployed at scale. Until privacy rules and interoperability frameworks become more aligned, the forensic genomics market will continue to operate below its full technical potential in cross border casework and collaborative investigations.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Product Type: Software and Services Poised to Outpace Hardware

Instruments accounted for 47.92% of the forensic genomics market size in 2025, which reflects the central role of capillary electrophoresis platforms and the growing installed base of sequencing systems in routine laboratory operations. This segment remains foundational because every accredited workflow depends on validated hardware before evidence can move into interpretation or reporting. The installed base also creates long replacement cycles, which gives the forensic genomics market a durable equipment layer with steady recurring demand for consumables, service contracts, and workflow upgrades. In the forensic genomics industry, that pattern supports established vendors whose products are already embedded in laboratory standard operating procedures.

Software and services are projected to record the fastest growth at a 17.14% CAGR through 2031, which shows that value creation in the forensic genomics market is moving toward analysis and interpretation as workflows become more data-intensive. This shift is tied to probabilistic genotyping, cloud-capable laboratory information systems, and specialist genealogy or kinship tools that address analytical bottlenecks rather than sample extraction alone. The forensic genomics market is therefore seeing competitive strength shift from hardware exclusivity toward the ability to explain mixtures, document interpretation logic, and support secure, auditable workflows.

By Method: NGS Establishes Dominance, PCR Gains at the Field Level

Next-generation sequencing held 51.34% of the forensic genomics market share in 2025, making it the leading method segment and confirming that sequencing has moved from a specialist option into a mainstream forensic workflow. Its rise reflects better performance on degraded and low-quantity samples, which are common in difficult criminal investigations and unidentified human remains cases. The forensic genomics market has responded because laboratories increasingly need methods that can provide more information per sample without forcing multiple separate tests. 

Polymerase chain reaction is expected to grow at a 16.96% CAGR through 2031, which means the forensic genomics market still has strong momentum in a method that is older but highly adaptable to field deployment. This growth is linked to rapid DNA systems, which rely on PCR-based workflows and answer a different need than high-throughput sequencing. Capillary electrophoresis continues to hold an entrenched role in routine profiling, especially where laboratories prefer to improve discrimination within existing infrastructure rather than replace the full workflow. 

By Therapeutic Area: Paternity Testing Anchors Revenue, DVI Captures Investment

Paternity and familial testing held 39.68% of the forensic genomics market in 2025, which gave this area the largest revenue contribution among applications. Its strength comes from a broader demand base than criminal casework alone, because courts, family disputes, inheritance matters, immigration reviews, and direct relationship testing all create recurring use. That helps the forensic genomics market maintain demand even when government casework cycles fluctuate or public budgets tighten. In the forensic genomics industry, this balance between civil and criminal uses gives the revenue base greater resilience than a law enforcement-only model would provide.

Criminal investigation & cold case resolution are projected to expand at a 17.58% CAGR through 2031, which makes it the fastest-growing application in the forensic genomics market. Growth in this area reflects rising expectations for speed, batch handling, kinship matching, and operation in difficult field conditions rather than in controlled laboratory settings alone. The forensic genomics market is likely to see this application pull forward capital spending, where agencies want faster identification capacity for mass casualty response and missing persons work.

Geography Analysis

North America held 42.57% of the forensic genomics market share in 2025, which kept it in the leading regional position. The region’s advantage comes from the deepest laboratory network, the largest national DNA database, and stable public funding channels that continue to support casework expansion and technology refresh cycles. The proposed CODIS Access Modernization Act could widen the commercial base further by allowing eligible private laboratories to upload qualifying profiles directly to NDIS, which would expand demand beyond traditional public laboratories if enacted. 

Europe remains the second-largest regional block in the forensic genomics market, supported by strong accreditation discipline and a mature operational culture in countries such as Germany, the United Kingdom, and France. The region’s laboratories operate within a framework that places heavy weight on validation quality, proficiency testing, and interoperability across established DNA comparison systems. This keeps demand focused on standards-compliant kits and auditable software rather than on low-cost, lightly validated alternatives. Privacy rules also influence product design in the forensic genomics market, because vendors need workflows that support controlled access, secure handling, and defensible use of sensitive genetic data. As a result, Europe remains a high-quality revenue region where procurement is often driven by regulatory fit as much as by raw instrument performance.

Asia-Pacific is the fastest-growing region, with the forensic genomics market for the region projected to grow at an 18.21% CAGR through 2031. China is a major force behind that pace because a series of national forensic DNA standards that became effective from 2024 onward created a formal procurement path for laboratory construction, examination specifications, and NGS-based DNA examination. Japan’s revised DNA profiling guidance adds another layer of demand discipline by updating requirements for national database submissions. South Korea and Australia continue to provide established regional demand, while emerging Southeast Asian markets represent earlier-stage opportunities for future rollout. The recognition of China’s integrated one-hour forensic DNA detection system in 2026 also suggests that domestic innovation is becoming a more active force in the regional forensic genomics market, especially in field-deployable formats.